102 related articles for article (PubMed ID: 11844804)
1. Clinical link between p53 and angiogenesis in lung cancer.
Freemantle SJ; Dmitrovsky E
J Clin Oncol; 2002 Feb; 20(4):883-4. PubMed ID: 11844804
[No Abstract] [Full Text] [Related]
2. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer.
Strohmeyer D; Rössing C; Bauerfeind A; Kaufmann O; Schlechte H; Bartsch G; Loening S
Prostate; 2000 Nov; 45(3):216-24. PubMed ID: 11074523
[TBL] [Abstract][Full Text] [Related]
4. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis.
Niklińska W; Burzykowski T; Chyczewski L; Nikliński J
Lung Cancer; 2001 Dec; 34 Suppl 2():S59-64. PubMed ID: 11720743
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect.
Nishizaki M; Fujiwara T; Tanida T; Hizuta A; Nishimori H; Tokino T; Nakamura Y; Bouvet M; Roth JA; Tanaka N
Clin Cancer Res; 1999 May; 5(5):1015-23. PubMed ID: 10353734
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
8. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.
Masuya D; Huang C; Liu D; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Haba R; Yokomise H
Cancer; 2001 Nov; 92(10):2628-38. PubMed ID: 11745198
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.
Tsao MS; Liu N; Nicklee T; Shepherd F; Viallet J
Clin Cancer Res; 1997 Oct; 3(10):1807-14. PubMed ID: 9815567
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.
Rofstad EK; Halsør EF
Br J Cancer; 2002 Jan; 86(2):301-8. PubMed ID: 11870523
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and cancer metastasis: antiangiogenic therapy of human pancreatic adenocarcinoma.
Baker CH; Solorzano CC; Fidler IJ
Int J Clin Oncol; 2001 Apr; 6(2):59-65. PubMed ID: 11706751
[No Abstract] [Full Text] [Related]
12. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.
Bouvet M; Ellis LM; Nishizaki M; Fujiwara T; Liu W; Bucana CD; Fang B; Lee JJ; Roth JA
Cancer Res; 1998 Jun; 58(11):2288-92. PubMed ID: 9622060
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in rats.
Takahama M; Tsutsumi M; Tsujiuchi T; Kido A; Sakitani H; Iki K; Taniguchi S; Kitamura S; Konishi Y
Mol Carcinog; 1999 Apr; 24(4):287-93. PubMed ID: 10326865
[TBL] [Abstract][Full Text] [Related]
14. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K
Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996
[TBL] [Abstract][Full Text] [Related]
15. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
16. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.
Huang S; Robinson JB; Deguzman A; Bucana CD; Fidler IJ
Cancer Res; 2000 Oct; 60(19):5334-9. PubMed ID: 11034066
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
18. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
Zietz C; Rössle M; Haas C; Sendelhofert A; Hirschmann A; Stürzl M; Löhrs U
Am J Pathol; 1998 Nov; 153(5):1425-33. PubMed ID: 9811333
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
20. Spatial and temporal expression of angiogenic molecules during tumor growth and progression.
Kumar R; Kuniyasu H; Bucana CD; Wilson MR; Fidler IJ
Oncol Res; 1998; 10(6):301-11. PubMed ID: 9848101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
